Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes

被引：135

作者：

Gaudy, Caroline ^{[1
,2
,3
]}

Clevy, Celine ^{[1
,2
]}

Monestier, Sandrine ^{[1
,2
]}

Dubois, Noemie ^{[4
]}

Preau, Yanis ^{[4
]}

Mallet, Stephanie ^{[1
,2
]}

Richard, Marie-Aleth ^{[1
,2
,3
]}

Grob, Jean-Jacques ^{[1
,2
,3
]}

Valero, Rene ^{[4
,5
,6
]}

Beliard, Sophie ^{[4
,5
,6
,7
]}

机构：

[1] La Timone Hosp, AP HM, Dept Dermatol, Marseille, France

[2] La Timone Hosp, AP HM, Dept Oncol, Marseille, France

[3] INSERM, UMRS 911, F-13258 Marseille, France

[4] La Concept Hosp, AP HM, Dept Nutr Metab Dis & Endocrinol, Marseille, France

[5] Aix Marseille Univ, Fac Med, Marseille, France

[6] INSERM, UMR 1062, F-13258 Marseille, France

[7] INRA, UMR 1260, Marseille, France

来源：

DIABETES CARE | 2015年 / 38卷 / 11期

关键词：

D O I：

10.2337/dc15-1331

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E182 / E183

页数：2

共 5 条

[1] Low programmed cell death-1 (PD-1) expression in peripheral CD4+ T cells in Japanese patients with autoimmune type 1 diabetes [J].

Fujisawa, R. ;

Haseda, F. ;

Tsutsumi, C. ;

Hiromine, Y. ;

Noso, S. ;

Kawabata, Y. ;

Mitsui, S. ;

Terasaki, J. ;

Ikegami, H. ;

Imagawa, A. ;

Hanafusa, T. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 180 (03) :452-457

[2] Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy [J].

Hughes, Jing ;

Vudattu, Nalini ;

Sznol, Mario ;

Gettinger, Scott ;

Kluger, Harriet ;

Lupsa, Beatrice ;

Herold, Kevan C. .

DIABETES CARE, 2015, 38 (04) :e55-e57

[3] Fulminant type 1 diabetes - an important subtype in East Asia [J].

Imagawa, Akihisa ;

Hanafusa, Toshiaki .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (08) :959-964

[4] Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes [J].

Kochupurakkal, Nora M. ;

Kruger, Annie J. ;

Tripathi, Sudipta ;

Zhu, Bing ;

Adams, La Tonya ;

Rainbow, Daniel B. ;

Rossini, Aldo ;

Greiner, Dale L. ;

Sayegh, Mohamed H. ;

Wicker, Linda S. ;

Guleria, Indira .

PLOS ONE, 2014, 9 (02)

[5] Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial [J].

Robert, Caroline ;

Ribas, Antoni ;

Wolchok, Jedd D. ;

Hodi, F. Stephen ;

Hamid, Omid ;

Kefford, Richard ;

Weber, Jeffrey S. ;

Joshua, Anthony M. ;

Hwu, Wen-Jen ;

Gangadhar, Tara C. ;

Patnaik, Amita ;

Dronca, Roxana ;

Zarour, Hassane ;

Joseph, Richard W. ;

Boasberg, Peter ;

Chmielowski, Bartosz ;

Mateus, Christine ;

Postow, Michael A. ;

Gergich, Kevin ;

Elassaiss-Schaap, Jeroen ;

Li, Xiaoyun Nicole ;

Iannone, Robert ;

Ebbinghaus, Scot W. ;

Kang, S. Peter ;

Daud, Adil .

LANCET, 2014, 384 (9948) :1109-1117

← 1 →